Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CES2 | O00748 | 3/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | GMNN | O75496 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | PPARA | Q07869 | 2/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 6/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
| ▸ | CTSB | P07858 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 4/20 | 0.35 |
| ▸ | PLA2G6 | O60733 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4101877 | 0.98 | CA2 (0.47) | CA2CES2TP53HSD17B10GMNN | |
| SCHEMBL6691473 | 0.98 | CA2 (0.47) | CA2CES2TP53HSD17B10GMNN | |
| SCHEMBL15500216 | 0.98 | CA2 (0.47) | CA2CES2TP53HSD17B10GMNN | |
| SCHEMBL11340050 | 0.95 | CA2 (0.45) | CA2CES2TP53HSD17B10GMNN | |
| SCHEMBL11333558 | 0.95 | CA2 (0.45) | CA2CES2TP53HSD17B10GMNN | |
| SCHEMBL6687367 | 0.95 | CA2 (0.45) | CA2CES2TP53HSD17B10GMNN | |
| SCHEMBL27617655 | 0.95 | CA2 (0.45) | CA2CES2TP53HSD17B10GMNN | |
| SCHEMBL5029419 | 0.92 | — | — | |
| SCHEMBL10957642 | 0.90 | HSD17B10 (0.38) | CA2CES2TP53HSD17B10GMNN | |
| SCHEMBL1082107 | 0.89 | TP53 (0.38) | CA2CES2TP53HSD17B10GMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114478150-B | S-deuterated methyl-aryl sulfonyl thioester compound and synthetic method and application thereof | 浙江工业大学 | 2024-04-09 | — | — | CN | claimed |
| CN-117164488-A | Method for synthesizing (E) -beta-thio vinyl sulfone compound by using organic semiconductor carbon nitride as catalyst | 化学与精细化工广东省实验室 | 2023-12-05 | — | — | CN | claimed |
| CN-114478150-A | S-deuterated methyl-aryl sulfonyl thioester compound and synthesis method and application thereof | 浙江工业大学 | 2022-05-13 | — | — | CN | claimed |
| US-9999902-B2 | Non-sticky erasable media with overcoat | XEROX CORPORATION (US) | 2018-06-19 | — | — | US | claimed |
| US-9507249-B2 | Non-sticky erasable media with overcoat | XEROX CORPORATION (US) | 2016-11-29 | — | — | US | claimed |
| US-20140073602-A9 | NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2014-03-13 | — | — | US | claimed |
| US-8545738-B2 | Stabilized photochromic ink for reusable paper annotation | XEROX CORPORATION (US) | 2013-10-01 | — | — | US | claimed |
| US-20130184237-A1 | NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2013-07-18 | — | — | US | claimed |
| EP-2591009-A1 | NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES | Fresenius Kabi Deutschland GmbH (DE) | 2013-05-15 | — | — | EP | claimed |
| US-8303858-B2 | Photochromic polymer with binder | XEROX CORPORATION (US) | 2012-11-06 | — | — | US | claimed |
| US-20080311491-A1 | INKLESS REIMAGEABLE PRINTING PAPER AND METHOD | XEROX CORPORATION (US) | 2008-12-18 | — | — | US | claimed |
| EP-2003496-A1 | Inkless Reimageable Printing Paper and Method | Xerox Corporation (US) | 2008-12-17 | — | — | EP | claimed |
| EP-2003492-A1 | Inkless Reimageable Printing Paper and Method | Xerox Corporation (US) | 2008-12-17 | — | — | EP | claimed |
| US-7381506-B2 | Reimageable paper | XEROX CORPORATION (US) | 2008-06-03 | — | — | US | claimed |
| US-7316875-B2 | Photochromic paper with improved bistability | XEROX CORPORATION (US) | 2008-01-08 | — | — | US | claimed |
| US-7229740-B2 | Reimageable paper | XEROX CORPORATION (US) | 2007-06-12 | — | — | US | claimed |
| US-20070072110-A1 | Substrate coated with a mixture of a solvent and an imaging layer containing a photochromic material exhibiting a reversible homogeneous-heterogeneous transition between a dispersed colorless state and a colored state that separates out of the solvent in the form of opaque, polydisperse crystals. | XEROX CORPORATION (US) | 2007-03-29 | — | — | US | claimed |
| US-20070054215-A1 | Substrate coated with a polymer binder and an imaging layer containing a photochromic material exhibiting a reversible homogeneous-heterogeneous transition between a dispersed colorless state and a colored state that separates out of the binder in the form of opaque, polydisperse crystals. | XEROX CORPORATION (US) | 2007-03-08 | — | — | US | claimed |
| US-20060251988-A1 | Photochromic paper with improved bistability | XEROX CORPORATION (US) | 2006-11-09 | — | — | US | claimed |
| US-4009087-A | N-HETERO AROMATIC, AND SULFOALKYL OR SULFOARYL SULFIDE | M&T CHEMICALS INC. (US) | 1977-02-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130184237-A1 | NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES | NOS2, NOS3, NOS1 | CA2 2768/4885CES2 169/4885TP53 3857/4885 |
| US-20140073602-A9 | NITRIC OXIDE DELIVERING HYDROXYALKYL STARCH DERIVATIVES | NOS2, NOS3, NOS1 | CA2 2768/4885CES2 169/4885TP53 3857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.